Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions.

by Jeffrey J Sutherland, Thomas M Daly, Xiong Liu, Keith Goldstein, Joseph A Johnston, Timothy P Ryan
Published 2015-01-01

Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registry.

by Joseph A Johnston, David R Nelson, Limin Zhang, Sarah E Curtis, James R Voelker, John R Wetterau
Published 2019-01-01

Prevalence and cardiometabolic correlates of ketohexokinase gene variants among UK Biobank participants.

by Joseph A Johnston, David R Nelson, Pallav Bhatnagar, Sarah E Curtis, Yu Chen, James G MacKrell
Published 2021-01-01

Usability of an Atrial Fibrillation Anticoagulation Decision-Support Tool

by Mark L. Wess MD, SM, Jason J. Saleem PhD, MS, Joel Tsevat MD, MPH, Sara E. Luckhaupt MD, MPH, Joseph A. Johnston MD, MSc, Ruth E. Wise MSN, Jonathan E. Kopke, Mark H. Eckman MD, MS
Published 2011-04-01